DailySand tracks regulatory arbitrage across AI, semiconductor infrastructure, capital markets, and critical minerals supply chains. Below are curated source items and daily digests where regulatory arbitrage appears in today's cross-sector intelligence briefing.
1 item across 1 digest
Chinese vape manufacturers are using nicotine analogs such as 6-methyl-nicotine—compounds that Big Tobacco researched but never commercialized—to circumvent US regulatory restrictions on nicotine content. This regulatory arbitrage creates a novel consumer product category and highlights gaps in international regulatory coordination for emerging chemicals.
Read original →
DailySand